Brugada Syndrome and QT Prolongation Syndrome

DOI 4 References
  • ONISHI Yoshihiko
    Department of Anesthesiology, National Cerebral and Cardiovascular Center

Bibliographic Information

Other Title
  • 特殊不整脈・状態と麻酔管理上の抗不整脈対策 （1）ブルガダ症候群　　（2）QTc延長とトルサデポアン

Search this article

Description

Brugada syndrome is defined as electrocardiographic (ECG) changes consisting of ST elevation in V1-V3 lead and is induced by ventricular fibrillation. This hereditary syndrome is often the cause of death in younger adult men, predominantly. Implantation of ICD is a definite therapy to prevent sudden death. <br>  QT prolongation syndrome (LQTS) is defined as prolonged QT interval (QTc > 440msec) and causes malignant ventricular arrhythmias to the development of torsade de pointes. This syndrome is heredity or induced by several drugs. The first therapy for LQTS is intravenous adopted be-ta blockers, mexiletine and verapamil. However, patients who have had mortal arrhythmias, including VF, are indicated for ICD implantation. <br>  Anesthetic consideration of the patients with implanted ICD is to arrest the ICD function and attach the DC pads on the thorax during the operation.

Journal

References(4)*help

See more

Keywords

Details 詳細情報について

  • CRID
    1390282679735908352
  • NII Article ID
    130004450090
  • DOI
    10.2199/jjsca.32.601
  • ISSN
    13499149
    02854945
  • Text Lang
    ja
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top